Novartis AG
Glycoside derivatives and uses thereof

Last updated:

Abstract:

This invention relates to compounds represented by formula (I): ##STR00001## wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.

Status:
Grant
Type:

Utility

Filling date:

18 Feb 2020

Issue date:

24 May 2022